Concepedia

Pegfilgrastim versus filgrastim after high-dose chemotherapy and autologous peripheral blood stem cell support

Luca Castagna, Stéfania Bramanti, Alessandro Levis, Mariagrazia Michieli, A. Anastasia, Rita Mazza, Laura Giordano, Barbara Sarina, Elisabetta Todisco, Anna Ines Gregorini,

Annals of Oncology · 2009 · 23 citations · 22 references

DOIFull text

Open access

Concepts

References

22

2006 Update of Recommendations for the Use of White Blood Cell Growth Factors: An Evidence-Based Clinical Practice Guideline

Thomas J. Smith, James Khatcheressian, Gary H. Lyman et al. · Journal of Clinical Oncology · 2006 · 1.6K citations · Full text

, , +17

Randomised trial of filgrastim-mobilised peripheral blood progenitor cell transplantation versus autologous bone-marrow transplantation in lymphoma patients

Norbert Schmitz, Peter Dreger, David C. Linch et al. · The Lancet · 1996 · 617 citations

, , +14

Blinded, Randomized, Multicenter Study to Evaluate Single Administration Pegfilgrastim Once per Cycle Versus Daily Filgrastim as an Adjunct to Chemotherapy in Patients With High-Risk Stage II or Stage III/IV Breast Cancer

Frankie A. Holmes, Joyce O’Shaughnessy, S. Vukelja et al. · Journal of Clinical Oncology · 2002 · 517 citations

, , +17

Comparable efficacy and safety profiles of once-per-cycle pegfilgrastim and daily injection filgrastim inchemotherapy-induced neutropenia: a multicenterdose-finding study in women with breast cancer

Frankie A. Holmes, Stephen E. Jones, Joyce O’Shaughnessy et al. · Annals of Oncology · 2002 · 292 citations · Full text

, , +11

Randomized, Dose-Escalation Study of SD/01 Compared With Daily Filgrastim in Patients Receiving Chemotherapy

Eileen Johnston, Jeffrey Crawford, Susan Blackwell et al. · Journal of Clinical Oncology · 2000 · 268 citations

, , +17